Who has invested in AM Pharma?

LSP, Andera Partners, Forbion, Ysios Capital, Kurma Partners, ID Invest Partners are named among the investors backing AM Pharma.

AM Pharma Funding: $176M Raised, Series C (2020)

AM Pharma funding overview

AM Pharma is based in Bunnik, The Netherlands. AM Pharma has raised $176M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in March 2020. The round record for AM Pharma runs through 2020; nothing later has been disclosed. Investors on record include LSP, Andera Partners, Forbion, Ysios Capital, Kurma Partners, ID Invest Partners and 4 others. 10 distinct backers are named across the disclosed rounds.

AM Pharma at a glance

Total raised: $176M
Latest round: Series C
Latest round date: March 2020
Headquarters: Bunnik, The Netherlands
Notable investors: LSP, Andera Partners, Forbion, Ysios Capital, Kurma Partners, ID Invest Partners, BB Pureos Bioventures, Gilde Healthcare

Frequently asked about AM Pharma funding

How much has AM Pharma raised?: AM Pharma has raised $176M in total disclosed funding across the rounds on record.
Who has invested in AM Pharma?: LSP, Andera Partners, Forbion, Ysios Capital, Kurma Partners, ID Invest Partners are named among the investors backing AM Pharma.
What was the latest AM Pharma funding round?: The most recent disclosed round is a Series C, announced in March 2020.
Where is AM Pharma based?: AM Pharma is based in Bunnik, The Netherlands.
When did AM Pharma last raise?: The last disclosed AM Pharma round closed in March 2020 at Series C.

Totals shown for AM Pharma aggregate every disclosed round on file. To see how that compares, browse the companies in Bunnik and the investors behind them below.

AM Pharma Funding: $176M Raised, Series C (2020)

AM Pharma funding overview

AM Pharma at a glance

Frequently asked about AM Pharma funding

Companies related to AM Pharma (16)

Browse related funding lists (7)